We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smart Watches Could Identify Parkinson’s Disease Years before Symptoms Appear

By HospiMedica International staff writers
Posted on 10 Jul 2023

Parkinson's disease impacts brain cells known as dopaminergic neurons, predominantly located in an area called the substantia nigra. More...

This condition leads to motor symptoms such as tremors, stiffness or rigidity, and slowed movements. Unfortunately, by the time these classic symptoms of Parkinson's become apparent, facilitating clinical diagnosis, over half of the substantia nigra cells have already died. Consequently, there's an urgent need for cost-effective, reliable, and readily available methods to detect early changes, thereby permitting intervention before the disease inflicts extensive brain damage. Now, new research has revealed that smartwatches could potentially identify Parkinson's up to seven years prior to the onset of characteristic symptoms and clinical diagnosis.

A study led by scientists at Cardiff University (Wales, UK) analyzed data gathered by smartwatches over a week, focusing on the speed of participants' movements. The researchers examined data derived from 103,712 UK Biobank participants who wore medical-grade smartwatches for a week between 2013 and 2016. These devices continuously measured average acceleration, or movement speed, throughout the seven-day span. The team compared data from a subset of participants already diagnosed with Parkinson's disease to another group diagnosed up to seven years after the smartwatch data collection. They also compared these groups to age and sex-matched healthy individuals.

The researchers discovered that they could accurately predict, using artificial intelligence (AI), who would eventually develop Parkinson's disease. Not only could they differentiate these participants from the healthy controls, but they also demonstrated that the AI could identify individuals in the general population who would later develop Parkinson's. This method was found to be more precise than any other risk factor or recognized early disease sign in predicting Parkinson's development. The machine learning model was also capable of predicting the time to diagnosis. According to the researchers, this could serve as a novel screening tool for Parkinson's disease, facilitating detection at much earlier stages than current methods permit.

“Smartwatch data is easily accessible and low-cost. As of 2020, around 30 percent of the UK population wear smart watches. By using this type of data, we would potentially be able to identify individuals in the very early stages of Parkinson’s disease within the general population,” said study leader Dr. Cynthia Sandor, Emerging Leader at the UK Dementia Research Institute at Cardiff University.

“We have shown here that a single week of data captured can predict events up to seven years in the future. With these results we could develop a valuable screening tool to aid in the early detection of Parkinson’s. This has implications both for research, in improving recruitment into clinical trials, and in clinical practice, in allowing patients to access treatments at an earlier stage, in future when such treatments become available,” added Dr. Sandor

Related Links:
Cardiff University 


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.